Although the follow-up period was relatively short, TUFT1 overexpression was negatively correlated with the patient survival rate, indicating that TUFT1 may be involved in breast cancer progression, and serve as a prognostic factor for this type of cancer. Here, TUFT1 is linked to breast carcinoma.